Senior researcher
Norwegian Institute of Public Health
Oslo, Norway
Leo Pharma (Contracted Research, participation in regulator-mandated phase IV study, with funds paid to his institution (no personal fees) and with no relation to the work reported in this abstract)Novo Nordisk (Contracted Research, participation in regulator-mandated phase IV study, with funds paid to his institution (no personal fees) and with no relation to the work reported in this abstract)
Lisdexamfetamine in Early Pregnancy and Risk of Major Congenital Malformations
Friday, August 26, 2022
1:45 PM - 2:00 PM CEST